FindTrial
Sign In

Study of the effect of sublingual immunotherapy which is one of the treatment methods of Japanese cedar pollinosis and movement of concentration of protein which carries immunity in blood

Study of the effect of sublingual immunotherapy for Japanese cedar pollinosis and the change of immunoglobulin in blood - Study of sublingual immunotherapy of Japanese cedar

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036471
Enrollment
25
Registered
2019-04-12
Start date
2015-05-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese cedar pollinosis

Interventions

We will perform a total of four blood sampling and interviews until June 2016 for patients who have begun cidatoren (the medicine of sublingual immunotherapy for Japanese ceder pollinosis) between Jun

Sponsors

Nippon Medical School Musashi Kosugi Hospital
Lead Sponsor
Nippon medical school
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are positive for Japanese cedar specific antibody in blood exam

Exclusion criteria

Exclusion criteria: Patients who are negative for Japanese cedar specific antibody in blood exam

Design outcomes

Primary

MeasureTime frame
We performed blood sampling and interviews for each patient in January, March, and June 2016. The patient serum was used to measure 11 items such as IgG4.—

Secondary

MeasureTime frame
We performed blood sampling and interviews for each patient in January, March, and June 2016. The patient serum was used to measure 11 items (IgG4,IgE,IL-2,IL-5,IL-10,IL-12p70,IL-17,GM-CSF,VEGF, IFN-g,TGF-b1). The symptom score are six items, i.e., runny nose, sneezing, stuffy nose, itchy nose, itchy eyes, and watery eyes.—

Countries

Japan

Contacts

Public ContactEriko Takahara

Nippon Medical School Musashi Kosugi Hospital Department of Oto-Rhino-Laryngology

eriko.star@gmail.com044-733-5181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026